A.R.M.O.R. – A Tool for Evaluating Polypharmacy

Executive Summary

 

Many patients, especially the elderly, are on various forms of medication, leading to higher risks of adverse drug reactions (ADRs) and drug-drug interactions (DDIs). Addressing this complex issue of polypharmacy requires collation of multiple factors, including patient clinical profiles, functional status, and evidence-based data on potentially harmful medication interactions. ARMOR is an interactive tool developed by an MSU physician that can be used to successfully evaluate polypharmacy risks in elderly patients.

 

Description of Technology

 

ARMOR is comprised of five steps—Assess, Review, Minimize, Optimize, and Reassess. This step-wise process allows clinicians to address possible DDIs and ADRs and minimize risk by eliminating nonessential medications. ARMOR has been implemented in a clinical setting and shown to decrease the number of medications elderly patients are on, as well as decrease falls and potentially harmful behaviors in their facility. The ARMOR instrument has been shown to allow for more efficacious and safe treatment of senior patients.

 

Key Benefits

  • Improved safety for patients that receive various forms of medication.
  • Better monitoring and evaluation of polypharmacy in elderly patients
  • Possible reduction of number of prescribed medications

 

Applications

  • Polypharmacy monitoring
  • Geriatric care

 

 

Licensing Rights Available

 

Full licensing rights available.

 

Inventors: Raza Haque

 

Tech ID: TEC2015-0056

 

Patent Information:

For Information, Contact:

Randy Ramharack
Technology Manager
Michigan State University
ramharac@msu.edu
Inventors:
Raza Haque
Keywords: